NeVa™ First Clinical Experience Data Presented at the International Stroke Conference
From Val D’Isere, France to Honolulu, Vesalio’s early clinical experience data is being presented globally.
NeVa™ Drop Zone Effect – Initial Experience Presented at ABC Win
On January 18, 2019, Professor Serdar Geyik (Istanbul Istinye University) presented his early NeVa experience at the ABC-WIN Seminar in Val D’Isere, France.
Vesalio Initiates Full Commercial Launch of NeVa at the 10th Anniversary of ESMINT
Vesalio announces it has initiated the full commercial European launch of its NeVa neurothrombectomy platform at the 10th annual congress of the European Society of Minimally Invasive Neurological Therapy.
Vesalio Reports Expansion of Commercial Distribution, Additional Published Data on the NeVa™ System
Vesalio announces it has executed multiple exclusive distribution agreements in Europe and now has market coverage in 25 countries for the NeVa Neurothrombectomy System.
Positive Results in Early NeVa™ Human Thrombectomy Procedures
Vesalio announces it has completed European enrollment of the first twenty-five human cases in a post-market registry of the proprietary NeVa™ neurothrombectomy platform for the treatment of stroke.
Vesalio Announces NeVa™ Stroke Treatment Product CE Mark Certification
Vesalio announces the CE Mark certification of its first product line, the proprietary NeVa™ neurothrombectomy platform for the treatment of stroke.
